Abstract
Objective: The present study was aimed to develop of the Guanfacine Hydrochloride Extended-release tablets for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The dosage regimen of Guanfacine Hydrochloride is 4 mg at every 6 h. The concentration of Guanfacine in plasma is fluctuating. Hence, to control the plasma fluctuation and to avoid toxicity problem, Guanfacine Hydrochloride was chosen as a drug with an aim to develop an extended release system for 20 to 24 h.
 Methods: The design of the system was based on the use of pH-dependent polymer (Hydroxypropyl Methyl Cellulose), pH-independent polymer (Eudragit L 100-55), along with microenvironment modifiers such as organic acid (Fumaric acid) were used in the formulation. Drug-excipient compatibility was studied by FTIR. Before compression, the granules were evaluated for precompression parameters such as bulk density, tapped density, an angle of repose, compressibility index and Hausner’s ratio. After compression, evaluation tests of tablets such as general appearance, hardness, thickness, weight variation, friability, content uniformity, in vitro release studies and stability studies were performed.
 Results: Out of 9 formulations, the drug release was found to be within the innovator formulation F9. The stability study of formulation F9 revealed there was no significant change in physical and chemical properties of drug stored at 40 °C/75 % RH, 30 °C/65 % RH, 25 °C/60 % RH for 2 mo.
 Conclusion: Optimized formulation batch F9 showed highest F2 value which indicates similarity with innovator product. The study indicates that Guanfacine Hydrochloride Extended-release tablet was successfully developed.
Highlights
Oral drug delivery has been known for decades as the most widely utilized route of administration for delivery of drugs via different dosage forms due to its ease of administration, high patient compliance and flexibility in the design of dosage form
The study indicates that Guanfacine Hydrochloride Extended-release tablet was successfully developed
It is recognized that many patients can benefit from drugs intended for chronic administration by maintaining the plasma level within a safe effective range [3]
Summary
Oral drug delivery has been known for decades as the most widely utilized route of administration for delivery of drugs via different dosage forms due to its ease of administration, high patient compliance and flexibility in the design of dosage form. Conventional oral drug delivery systems are slowly fading away in the market owing to disadvantages. These delivery systems produce fluctuation of drug plasma level that either exists at a safe therapeutic level or quickly falls below the minimum effective level. This effect is usually totally dependent on the particular agent’s biological half-life, the frequency of administration and release rate. It is recognized that many patients can benefit from drugs intended for chronic administration by maintaining the plasma level within a safe effective range [3]. Extended oral drug delivery systems are highly recognized today for their benefits, improving the disadvantages of conventional drug delivery systems
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
